[
  {
    "ts": "2025-10-27T18:00:00+00:00",
    "headline": "3 Dividend-Paying Drug Stocks to Buy at a Discount",
    "summary": "Some of the largest drugmakers in the world are trading at attractive valuations. Are they worth buying?",
    "url": "https://www.fool.com/investing/2025/10/27/3-dividend-paying-drug-stocks-to-buy-at-a-discount/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "79bbef28-75bd-32be-9c45-f67724848f79",
      "content": {
        "id": "79bbef28-75bd-32be-9c45-f67724848f79",
        "contentType": "STORY",
        "title": "3 Dividend-Paying Drug Stocks to Buy at a Discount",
        "description": "",
        "summary": "Some of the largest drugmakers in the world are trading at attractive valuations. Are they worth buying?",
        "pubDate": "2025-10-27T18:00:00Z",
        "displayTime": "2025-10-27T18:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/ab23a5fdd8ea5deef2387d97aec4431f",
          "originalWidth": 1200,
          "originalHeight": 801,
          "caption": "A medical professional filling a needle from a bottle of medicine.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/spl0VkP2bhUd5OixVV6fdg--~B/aD04MDE7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/ab23a5fdd8ea5deef2387d97aec4431f.cf.webp",
              "width": 1200,
              "height": 801,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OsuMwEZtOzkeAL.qEkDHOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/ab23a5fdd8ea5deef2387d97aec4431f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/27/3-dividend-paying-drug-stocks-to-buy-at-a-discount/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-dividend-paying-drug-stocks-180000224.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T16:45:00+00:00",
    "headline": "Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences",
    "summary": "Saint-Herblain (France), October 27, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe. Valneva will host moderated “fireside chat” presentations to discuss the Company’s key value drivers and upcoming catalysts, primarily the upcoming Phase 3 trial outcomes for VLA15, the Company",
    "url": "https://finance.yahoo.com/news/valneva-present-hold-investor-meetings-164500869.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "e7b9fcd3-b882-3799-937b-5bb8ab256f9c",
      "content": {
        "id": "e7b9fcd3-b882-3799-937b-5bb8ab256f9c",
        "contentType": "STORY",
        "title": "Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences",
        "description": "",
        "summary": "Saint-Herblain (France), October 27, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe. Valneva will host moderated “fireside chat” presentations to discuss the Company’s key value drivers and upcoming catalysts, primarily the upcoming Phase 3 trial outcomes for VLA15, the Company",
        "pubDate": "2025-10-27T16:45:00Z",
        "displayTime": "2025-10-27T16:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900",
          "originalWidth": 960,
          "originalHeight": 140,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5.NO6z9tDSxyaBq0T2lbJw--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900.cf.webp",
              "width": 960,
              "height": 140,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/35yjCOUqpndcE5v.gVjmEA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/valneva-present-hold-investor-meetings-164500869.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/valneva-present-hold-investor-meetings-164500869.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INRLF"
            },
            {
              "symbol": "VALN"
            },
            {
              "symbol": "VLA.PA"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T16:21:22+00:00",
    "headline": "What Is 1 of the Best Pharmaceutical Stocks to Buy Now?",
    "summary": "This pharma giant is entering the rapidly expanding market for weight loss drugs.",
    "url": "https://www.fool.com/investing/2025/10/27/what-is-1-of-best-pharmaceutical-stocks-buy-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "157e9131-4e89-3318-a389-106146a84e79",
      "content": {
        "id": "157e9131-4e89-3318-a389-106146a84e79",
        "contentType": "STORY",
        "title": "What Is 1 of the Best Pharmaceutical Stocks to Buy Now?",
        "description": "",
        "summary": "This pharma giant is entering the rapidly expanding market for weight loss drugs.",
        "pubDate": "2025-10-27T16:21:22Z",
        "displayTime": "2025-10-27T16:21:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/5dee2622df65f71d9c939f098cf27be9",
          "originalWidth": 1400,
          "originalHeight": 787,
          "caption": "Healthcare lab technicians doing research.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/P_n2gqHYH2n7t8Hk5uAkJg--~B/aD03ODc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/5dee2622df65f71d9c939f098cf27be9.cf.webp",
              "width": 1400,
              "height": 787,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D0mBNVjiBKsYc4i9lC.C1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/5dee2622df65f71d9c939f098cf27be9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/27/what-is-1-of-best-pharmaceutical-stocks-buy-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-best-pharmaceutical-stocks-buy-162122563.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T16:15:00+00:00",
    "headline": "Should You Buy Pfizer Stock Before Nov. 4?",
    "summary": "The pharma giant is slated to report its latest quarterly numbers next week.",
    "url": "https://www.fool.com/investing/2025/10/27/should-you-buy-pfizer-stock-before-nov-4/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "5d2b1da2-e0ae-3095-b585-09e761bccfeb",
      "content": {
        "id": "5d2b1da2-e0ae-3095-b585-09e761bccfeb",
        "contentType": "STORY",
        "title": "Should You Buy Pfizer Stock Before Nov. 4?",
        "description": "",
        "summary": "The pharma giant is slated to report its latest quarterly numbers next week.",
        "pubDate": "2025-10-27T16:15:00Z",
        "displayTime": "2025-10-27T16:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/bdad07d33a35ef4bb2da4fbe90eac128",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A team of scientists reviewing results in a lab.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/U4.nVfhzt0u7vZdeDsC9Cw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/bdad07d33a35ef4bb2da4fbe90eac128.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bX1Z4dwgVnvOa_u2Q5z8Kg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/bdad07d33a35ef4bb2da4fbe90eac128.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/27/should-you-buy-pfizer-stock-before-nov-4/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-pfizer-stock-nov-4-161500393.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T13:17:00+00:00",
    "headline": "Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?",
    "summary": "Bristol-Myers Squibb's Q3 results hinge on rising demand for new therapies like Opdivo and Camzyos amid legacy-drug declines.",
    "url": "https://finance.yahoo.com/news/buy-hold-sell-bmy-stock-131700471.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "46c655d6-a65e-33c0-8669-9cae2617ed00",
      "content": {
        "id": "46c655d6-a65e-33c0-8669-9cae2617ed00",
        "contentType": "STORY",
        "title": "Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?",
        "description": "",
        "summary": "Bristol-Myers Squibb's Q3 results hinge on rising demand for new therapies like Opdivo and Camzyos amid legacy-drug declines.",
        "pubDate": "2025-10-27T13:17:00Z",
        "displayTime": "2025-10-27T13:17:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-hold-sell-bmy-stock-131700471.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-hold-sell-bmy-stock-131700471.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T12:00:00+00:00",
    "headline": "2 Unstoppable Health Care Giants to Buy Right Now for Less Than $1,000",
    "summary": "These two healthcare giants are doing what they need to do to get their businesses rocking and rolling again.",
    "url": "https://www.fool.com/investing/2025/10/27/2-unstoppable-health-care-giants-to-buy-right-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "14a3d160-6d3f-34b2-a1ee-3c608e8956a7",
      "content": {
        "id": "14a3d160-6d3f-34b2-a1ee-3c608e8956a7",
        "contentType": "STORY",
        "title": "2 Unstoppable Health Care Giants to Buy Right Now for Less Than $1,000",
        "description": "",
        "summary": "These two healthcare giants are doing what they need to do to get their businesses rocking and rolling again.",
        "pubDate": "2025-10-27T12:00:00Z",
        "displayTime": "2025-10-27T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/fe98ee98b836267a566830ce16c04341",
          "originalWidth": 1369,
          "originalHeight": 800,
          "caption": "A finger flipping dice that spell out long term and short term.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yikZRjmSPkSKXZ10J5tsSg--~B/aD04MDA7dz0xMzY5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/fe98ee98b836267a566830ce16c04341.cf.webp",
              "width": 1369,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Jrtnoyf2EJfXRHHt6KV3aQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/fe98ee98b836267a566830ce16c04341.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/27/2-unstoppable-health-care-giants-to-buy-right-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-unstoppable-health-care-giants-120000880.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T09:43:00+00:00",
    "headline": "Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030",
    "summary": "Vertex appears to be by far the better buy right now.",
    "url": "https://www.fool.com/investing/2025/10/27/prediction-vertex-pharmaceuticals-will-be-worth-mo/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "e12ba376-46bd-3a5b-a443-cee854c16bd1",
      "content": {
        "id": "e12ba376-46bd-3a5b-a443-cee854c16bd1",
        "contentType": "STORY",
        "title": "Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030",
        "description": "",
        "summary": "Vertex appears to be by far the better buy right now.",
        "pubDate": "2025-10-27T09:43:00Z",
        "displayTime": "2025-10-27T09:43:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/46d6eeb91d90cf50132b34d2a146bc3a",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Doctor holding patient's hands.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NoBMo9Ua30jTr0d46Ed6Bw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/46d6eeb91d90cf50132b34d2a146bc3a.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sS7Pr3zhfR1lcGWgQa3Tyg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/46d6eeb91d90cf50132b34d2a146bc3a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/27/prediction-vertex-pharmaceuticals-will-be-worth-mo/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/prediction-vertex-pharmaceuticals-worth-more-094300795.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T08:30:00+00:00",
    "headline": "3 Healthcare Stocks Paying the Highest Dividends of 2025",
    "summary": "If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them.",
    "url": "https://www.fool.com/investing/2025/10/27/healthcare-stocks-paying-highest-dividends-2025/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "ed74543f-3358-3d69-b15b-fea103a1e837",
      "content": {
        "id": "ed74543f-3358-3d69-b15b-fea103a1e837",
        "contentType": "STORY",
        "title": "3 Healthcare Stocks Paying the Highest Dividends of 2025",
        "description": "",
        "summary": "If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them.",
        "pubDate": "2025-10-27T08:30:00Z",
        "displayTime": "2025-10-27T08:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/9aa51609efa92a328023cf9fbf3340b3",
          "originalWidth": 1199,
          "originalHeight": 797,
          "caption": "Three people standing on boxes in a desert looking through telescopes.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UBZCWtCRLaTDgVCEGnh_zA--~B/aD03OTc7dz0xMTk5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/9aa51609efa92a328023cf9fbf3340b3.cf.webp",
              "width": 1199,
              "height": 797,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WHw5FKkAizZDN1UvF.Q15Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/9aa51609efa92a328023cf9fbf3340b3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/27/healthcare-stocks-paying-highest-dividends-2025/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-healthcare-stocks-paying-highest-083000220.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "OHI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T08:00:00+00:00",
    "headline": "Merck’s oncology prospects could portend a post-Keytruda future",
    "summary": "Can the pharma giant offset potential losses from its megablockbuster with a strong suite of contenders?",
    "url": "https://www.pharmavoice.com/news/keytruda-merck-pipeline-cancer-oncology/803771/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "8784c174-889a-36e1-8268-dfa36a051da1",
      "content": {
        "id": "8784c174-889a-36e1-8268-dfa36a051da1",
        "contentType": "STORY",
        "title": "Merck’s oncology prospects could portend a post-Keytruda future",
        "description": "",
        "summary": "Can the pharma giant offset potential losses from its megablockbuster with a strong suite of contenders?",
        "pubDate": "2025-10-27T08:00:00Z",
        "displayTime": "2025-10-27T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/f31ca00f9e76c858c91413db6a53edf1",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Merck & Co. logo displayed on the exterior of their research facility in San Francisco, Calif., on Sep. 21, 2020.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OiosX7byQWb8CBILKYDBbQ--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/f31ca00f9e76c858c91413db6a53edf1.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mEnv_6A7ha6jnANKMZnHcw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/f31ca00f9e76c858c91413db6a53edf1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/keytruda-merck-pipeline-cancer-oncology/803771/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-oncology-prospects-could-portend-080000725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]